Rights Offering Calculator

Evaluating Shareholder Purchase Opportunities

The rights offering calculator analyzes the value of rights issued in a corporate rights offering, helping you decide whether to exercise your rights, sell them, or understand the cost of letting them expire. Rights offerings give existing shareholders the opportunity to purchase additional shares at a discount to market price, maintaining proportional ownership while providing capital to the issuing company. The calculator quantifies the value of these rights and compares outcomes under different action scenarios.

Rights offerings require shareholders to make active decisions within limited timeframes. Unlike stock splits or spin-offs where your position adjusts automatically, rights have expiration dates—typically two to six weeks—after which unexercised rights become worthless. The calculator provides the analysis needed to make informed decisions before these deadlines, comparing the costs and benefits of exercising versus selling versus inaction.

Understanding rights offerings matters because they directly affect your investment through dilution. Shareholders who neither exercise nor sell their rights suffer value loss as new shares dilute their ownership. The calculator quantifies this dilution cost, demonstrating why ignoring a rights offering is almost always the wrong choice.

How Rights Offerings Work

In a rights offering, companies distribute subscription rights to existing shareholders, typically one right per share owned. These rights entitle you to purchase additional shares at a predetermined subscription price, usually 15-30% below current market price. The ratio of rights needed per new share varies by offering—you might need five rights to purchase one new share, or ten rights, or any other ratio the company sets.

Consider owning 1,000 shares of a company trading at $50. The company announces a 1-for-5 rights offering at $40 subscription price. You receive 1,000 rights, which entitle you to purchase 200 new shares (1,000 / 5) at $40 each. Exercising all rights costs $8,000 (200 x $40) and gives you 1,200 total shares.

The subscription price discount creates intrinsic value in the rights themselves. Because you can buy shares below market price, the right to do so has monetary worth. This value belongs to you as a shareholder, but you must take action to capture it—either by exercising the rights or selling them.

Calculating Theoretical Ex-Rights Price

When a rights offering occurs, the stock price adjusts to reflect the dilution from new shares issued below market price. The Theoretical Ex-Rights Price (TERP) represents what the share price should be after the offering, calculated by combining the value of old shares with new shares at the subscription price.

TERP = (Old Shares x Current Price + New Shares x Subscription Price) / Total Shares After

For our example: TERP = (1,000 x $50 + 200 x $40) / 1,200 = ($50,000 + $8,000) / 1,200 = $48.33

The stock price falls from $50 to approximately $48.33 to reflect the discounted shares entering the market. This price drop doesn't harm shareholders who participate—their additional shares at $40 compensate for the lower price on existing shares. Shareholders who don't participate bear the dilution cost without receiving compensating shares.

The calculator computes TERP automatically, showing you what price to expect after the offering completes.

Determining the Value of Each Right

Each right has theoretical value based on the spread between TERP and subscription price, adjusted for the rights ratio:

Right Value = (TERP - Subscription Price) x Rights Ratio

In our example: Right Value = ($48.33 - $40) x (1/5) = $8.33 x 0.2 = $1.67 per right

Your 1,000 rights have total theoretical value of $1,670. This represents real value that you can capture either by exercising (buying shares below TERP) or selling the rights if they're tradeable.

The calculator determines individual right value and total rights value for your position, providing the key figure for deciding between exercising and selling.

Comparing Your Three Options

The calculator's primary function is comparing outcomes across your available choices: exercise, sell, or do nothing.

Exercising means paying the subscription price to convert rights into shares. You maintain proportional ownership, avoid dilution, and acquire shares below their theoretical value. The cost is the cash outlay required for the subscription price. Exercising makes sense if you want more shares and have available cash, and if you believe the stock is worth holding at even the higher post-offering price.

Selling rights (when tradeable) converts your rights to cash without requiring additional investment. You receive approximately the theoretical value of your rights but don't acquire additional shares. Your ownership percentage decreases due to dilution, but you're compensated with cash. This option suits shareholders who don't want more exposure or lack funds to exercise.

Doing nothing allows rights to expire worthless. Your share count stays the same, but share price falls to TERP while you receive no compensation. This is almost always the worst outcome—pure value destruction. The calculator quantifies this loss to emphasize why inaction is costly.

Exercise Decision Factors

Beyond pure mathematics, several factors influence whether exercising makes sense for your situation.

Cash availability is the primary practical constraint. Exercising requires significant capital outlay—in our example, $8,000 to exercise fully. If you lack available cash, selling rights becomes the only way to capture their value.

Investment conviction matters because exercising increases your position size. If you're bullish on the company's prospects, exercising at a discount represents an attractive opportunity. If you've lost confidence in the company (rights offerings sometimes signal financial stress), selling rights and reducing exposure might be preferable.

Portfolio concentration is a consideration when exercising would make one position disproportionately large. Even at attractive prices, increasing exposure to a single stock beyond prudent concentration limits isn't wise. Partial exercise—using some rights while selling others—can balance these concerns.

Selling Rights in the Market

Many rights offerings include tradeable rights that you can sell on the open market during the offering period. This allows shareholders without exercise capital to still capture their rights' value.

Tradeable rights have their own ticker symbol during the offering period. Market prices typically approximate theoretical value but may vary based on supply, demand, and market sentiment. If rights trade below theoretical value, exercising becomes relatively more attractive; if above, selling becomes more attractive.

The calculator shows theoretical right value, but check actual market prices before deciding. Transaction costs (commissions, bid-ask spreads) also affect net proceeds from selling rights.

Not all rights offerings include tradeable rights. Non-transferable rights can only be exercised or allowed to expire, eliminating the selling option. The calculator identifies which comparison is relevant based on your inputs.

Oversubscription Privileges

Some rights offerings include oversubscription privileges allowing shareholders to purchase additional shares beyond their basic entitlement if other shareholders don't fully exercise. Oversubscription lets you acquire even more discounted shares.

Oversubscription works as follows: after all basic subscriptions are filled, remaining shares (from unexercised rights) become available to shareholders who requested oversubscription. Allocation typically is pro-rata based on oversubscription requests.

If you're enthusiastic about the opportunity and have ample cash, requesting oversubscription maximizes your discounted share acquisition. The calculator focuses on basic entitlement; oversubscription represents additional upside if available and desired.

Dilution Effects for Non-Participants

The calculator quantifies dilution for shareholders who don't participate, making explicit why inaction destroys value.

In our example, not participating means owning 1,000 shares worth $48,333 after the offering (1,000 x $48.33 TERP) versus $50,000 before (1,000 x $50). The $1,667 loss equals the theoretical value of your unexercised rights—value that belonged to you but was forfeited through inaction.

Furthermore, your ownership percentage decreases. If the company had 10 million shares before and issues 2 million new shares, your 1,000 shares now represent 0.0083% ownership (1,000 / 12,000,000) versus 0.01% previously (1,000 / 10,000,000). Diluted ownership means smaller share of future earnings and dividends.

This dilution analysis often motivates shareholders to participate even when they weren't planning to add to the position.

Tax Implications of Rights

Rights offerings create tax considerations that vary based on your chosen action.

Exercising rights is generally not a taxable event. Your cost basis in the new shares equals the subscription price paid. These shares have a new holding period starting from the exercise date, separate from your original shares.

Selling rights produces taxable income. If the rights were received from shares with zero cost basis allocated to the rights (common treatment), proceeds are taxable as capital gain. The gain is long-term or short-term based on how long you've held the underlying shares.

Letting rights expire typically produces no tax consequence—you simply fail to capture value that could have been yours. No gain or loss is recognized, though the economic loss is very real.

Consult a tax professional for specific situations, as rights taxation can involve nuances based on offering structure and your particular circumstances.

Time Sensitivity and Deadlines

Rights offerings operate under strict deadlines. Missing the expiration date means losing all rights value regardless of your intentions. The calculator analysis is time-sensitive—it shows outcomes available only if you act before expiration.

Track the following dates. The record date determines who receives rights. The subscription period is when you can exercise or sell rights. The expiration date is the final deadline for exercising; unexercised rights become worthless after this date.

Calendar these dates immediately upon receiving rights offering notification. Many investors lose value simply by procrastinating past expiration—an entirely avoidable error that the calculator's scenario comparison helps prevent.

Using the Calculator for Decision Support

Input your current shares, current stock price, the rights ratio (new shares per existing shares), and the subscription price. The calculator outputs theoretical ex-rights price, value per right, total rights value, and comparative outcomes for exercising versus selling versus inaction.

Use the scenario comparison to guide your decision. If you have cash available and want to maintain or increase your position, exercising captures full value. If you prefer not to add more shares but want to capture value, selling rights (if tradeable) is optimal. If the analysis shows modest value and transaction costs would consume significant portions, partial exercise or scaled selling might make sense.

The calculator also reveals whether a rights offering is attractive relative to simply buying shares in the open market. Sometimes rights offerings price shares below levels available through normal purchase, creating genuine opportunity. Other times, the discount is modest relative to transaction friction.

---

The rights offering calculator transforms complex rights valuations into clear decision support, comparing outcomes across exercise, sale, and inaction scenarios. By quantifying theoretical ex-rights prices, individual right values, and dilution costs, the calculator ensures shareholders capture the value of their rights rather than forfeiting it through inaction or uninformed decisions. The time-limited nature of rights offerings makes this analysis essential for any shareholder facing such a corporate action.